BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29766242)

  • 41. An XBP-1 dependent bottle-neck in production of IgG subtype antibodies in chemically defined serum-free Chinese hamster ovary (CHO) fed-batch processes.
    Becker E; Florin L; Pfizenmaier K; Kaufmann H
    J Biotechnol; 2008 Jun; 135(2):217-23. PubMed ID: 18448183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased recombinant protein production owing to expanded opportunities for vector integration in high chromosome number Chinese hamster ovary cells.
    Yamano N; Takahashi M; Ali Haghparast SM; Onitsuka M; Kumamoto T; Frank J; Omasa T
    J Biosci Bioeng; 2016 Aug; 122(2):226-31. PubMed ID: 26850366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD.
    Sanches JGP; Xu Y; Yabasin IB; Li M; Lu Y; Xiu X; Wang L; Mao L; Shen J; Wang B; Hou L; Ju J; Zhao J; Song B
    Chem Biol Interact; 2018 Apr; 285():85-95. PubMed ID: 29477382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improved gene amplification by cell-cycle engineering combined with the Cre-loxP system in Chinese hamster ovary cells.
    Matsuyama R; Tsutsui T; Lee KH; Onitsuka M; Omasa T
    J Biosci Bioeng; 2015 Dec; 120(6):701-8. PubMed ID: 26108159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Attenuating apoptosis in Chinese hamster ovary cells for improved biopharmaceutical production.
    Henry MN; MacDonald MA; Orellana CA; Gray PP; Gillard M; Baker K; Nielsen LK; Marcellin E; Mahler S; Martínez VS
    Biotechnol Bioeng; 2020 Apr; 117(4):1187-1203. PubMed ID: 31930480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel CRISPR/Cas9-mediated knockout of LIG4 increases efficiency of site-specific integration in Chinese hamster ovary cell line.
    Wang C; Sun Z; Wang M; Jiang Z; Zhang M; Cao H; Luo L; Qiao C; Xiao H; Chen G; Li X; Liu J; Wei Z; Shen B; Wang J; Feng J
    Biotechnol Lett; 2022 Sep; 44(9):1063-1072. PubMed ID: 35918621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiR-767 promoted cell proliferation in human melanoma by suppressing CYLD expression.
    Zhang K; Guo L
    Gene; 2018 Jan; 641():272-278. PubMed ID: 29054757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of CYLD expression unleashes Wnt signaling in multiple myeloma and is associated with aggressive disease.
    van Andel H; Kocemba KA; de Haan-Kramer A; Mellink CH; Piwowar M; Broijl A; van Duin M; Sonneveld P; Maurice MM; Kersten MJ; Spaargaren M; Pals ST
    Oncogene; 2017 Apr; 36(15):2105-2115. PubMed ID: 27775078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trehalose suppresses antibody aggregation during the culture of Chinese hamster ovary cells.
    Onitsuka M; Tatsuzawa M; Asano R; Kumagai I; Shirai A; Maseda H; Omasa T
    J Biosci Bioeng; 2014 May; 117(5):632-8. PubMed ID: 24315529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screening.
    Kim HS; Dunshee DR; Yee A; Tong RK; Kim I; Farahi F; Hongo JA; Ernst JA; Sonoda J; Spiess C
    Protein Eng Des Sel; 2017 Sep; 30(9):627-637. PubMed ID: 28985411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CRISPR-interceded CHO cell line development approaches.
    Amiri S; Adibzadeh S; Ghanbari S; Rahmani B; Kheirandish MH; Farokhi-Fard A; Dastjerdeh MS; Davami F
    Biotechnol Bioeng; 2023 Apr; 120(4):865-902. PubMed ID: 36597180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced apoptosis in Chinese hamster ovary cells via optimized CRISPR interference.
    Xiong K; Marquart KF; la Cour Karottki KJ; Li S; Shamie I; Lee JS; Gerling S; Yeo NC; Chavez A; Lee GM; Lewis NE; Kildegaard HF
    Biotechnol Bioeng; 2019 Jul; 116(7):1813-1819. PubMed ID: 30883679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accelerated generation of gene-engineered monoclonal CHO cell lines using FluidFM nanoinjection and CRISPR/Cas9.
    Antony JS; Herranz AM; Mohammadian Gol T; Mailand S; Monnier P; Rottenberger J; Roig-Merino A; Keller B; Gowin C; Milla M; Beyer TA; Mezger M
    Biotechnol J; 2024 Apr; 19(4):e2300505. PubMed ID: 38651269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transient and stable CHO expression, purification and characterization of novel hetero-dimeric bispecific IgG antibodies.
    Rajendra Y; Peery RB; Hougland MD; Barnard GC; Wu X; Fitchett JR; Bacica M; Demarest SJ
    Biotechnol Prog; 2017 Mar; 33(2):469-477. PubMed ID: 27977915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dimer-dependent intrinsic/basal activity of the class B G protein-coupled receptor PAC1 promotes cellular anti-apoptotic activity through Wnt/β-catenin pathways that are associated with dimer endocytosis.
    Yu R; Cui Z; Li M; Yang Y; Zhong J
    PLoS One; 2014; 9(11):e113913. PubMed ID: 25426938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A BioDesign Approach to Obtain High Yields of Biosimilars by Anti-apoptotic Cell Engineering: a Case Study to Increase the Production Yield of Anti-TNF Alpha Producing Recombinant CHO Cells.
    Gulce Iz S; Inevi MA; Metiner PS; Tamis DA; Kisbet N
    Appl Biochem Biotechnol; 2018 Jan; 184(1):303-322. PubMed ID: 28685239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FX knockout CHO hosts can express desired ratios of fucosylated or afucosylated antibodies with high titers and comparable product quality.
    Louie S; Haley B; Marshall B; Heidersbach A; Yim M; Brozynski M; Tang D; Lam C; Petryniak B; Shaw D; Shim J; Miller A; Lowe JB; Snedecor B; Misaghi S
    Biotechnol Bioeng; 2017 Mar; 114(3):632-644. PubMed ID: 27666939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of apoptosis-resistant dihydrofolate reductase-deficient Chinese hamster ovary cell line.
    Lee SK; Lee GM
    Biotechnol Bioeng; 2003 Jun; 82(7):872-6. PubMed ID: 12701155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Generation of High Expressing Chinese Hamster Ovary Cell Pools Using the Leap-In Transposon System.
    Balasubramanian S; Peery RB; Minshull J; Lee M; White R; Kelly RM; Barnard GC
    Biotechnol J; 2018 Oct; 13(10):e1700748. PubMed ID: 29797786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CYLD Alterations in the Tumorigenesis and Progression of Human Papillomavirus-Associated Head and Neck Cancers.
    Cui Z; Kang H; Grandis JR; Johnson DE
    Mol Cancer Res; 2021 Jan; 19(1):14-24. PubMed ID: 32883697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.